Annals On Call - Fecal Transplantation for <i>C difficile</i>
Authors: Robert M. Centor, Dimitri M. Drekonja
Journal: Annals of Internal Medicine (2020)

Web Exclusives21 January 2020Annals On Call - Fecal Transplantation for C difficileFREERobert M. Centor, MD, Dimitri M. Drekonja, MD, MSRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author, Dimitri M. Drekonja, MD, MSMinneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota (D.M.D.)Search for more papers by this authorAuthor, Article and Disclosure Informationhttps://doi.org/10.7326/A19-0022 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses the treatment of recurrent C difficile infection with Dr. Dimitri Drekonja.Annals articles discussed include...Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study: https://annals.org/aim/fullarticle/2754174/incidence-bloodstream-infections-length-hospital-stay-survival-patients-recurrent-clostridioidesAbout Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article and Disclosure InformationAffiliations: Huntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota (D.M.D.)Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Drekonja has disclosed no conflicts of interest.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 21 January 2020Volume 172, Issue 2Page: OC1KeywordsBacteremiaCohort studiesConflicts of interestDiagnostic techniquesDisclosureHealth careHospital medicinePatientsTransplantation ePublished: 21 January 2020 Issue Published: 21 January 2020 CopyrightCopyright © 2020 by American College of Physicians. All Rights Reserved.Loading ...